Latest filing published 24 Jun 2026 for Centessa Pharmaceuticals plc. Read the official filing
No signal scores available.
All filings by Raphael Deferiere on record concern Centessa Pharmaceuticals plc. We count 2 filings; the first trade dates from 2 February 2026 and the latest from 24 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 24 June 2026, the filings show a transaction in Centessa Pharmaceuticals plc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations